Disruptive forces are converging on the business of family planning, a field that touches on hundreds of millions in the US and billions of lives globally. These trends are changing how we plan our reproductive lives and creating once-in-a generation opportunities for business innovators and investors.
FemTech, or female technology, an emerging sector that primarily addresses women's health, including fertility solutions, period-tracking apps, pregnancy and nursing care, women’s sexual wellness, and reproductive system health care is exciting venture investors and consumers. Fundamental advances in genomics, microfluidics and Big Data/ Artificial Intelligence are giving us new tools for realizing our personal goals. Business models are shifting as a fragmented mom-and-pop industry consolidates, standardizes and scales. Nowhere in medicine is the fight over affordable access to care and who pays for it more controversial.
CBSACNY is proud to offer its members an opportunity to hear the perspectives of leaders at the cutting edge of this business (see list of panelists and bios below), who will address how the technological advances are driving business innovation and opportunities.
Date: Wednesday, January 24, 2018
Time: 6:00-8:30 pm (networking opportunities before and after the panel presenstation; light refreshments served)
Location: Cooley LLC, 1114 Ave of Americas (West 43rd Street), New York, NY 10036
Tickets: $30 for CBSACNY members; $20 for CBSACNY student members; $45 for non-members; $60 at the door.
PANELISTS:
-- David Sable, MD (moderator), has spent decades in the worlds of business, medicine, academics and journalism. He is currently the life sciences portfolio manager for the Special Situations Funds, and an adjunct in the department of biological sciences at Columbia University, where he teaches entrepreneurship in biotechnology at Columbia’s Graduate School of Arts and Sciences.
-- Alan Copperman, MD, will speak on how science is driving business opportunities. He is the Director of the Division of Reproductive Endocrinology and Infertility and the Vice-Chairman of the Department of Obstetrics, Gynecology and Reproductive Science at The Icahn School of Medicine at Mount Sinai. Dr. Copperman serves as Medical Director of RMA of New York.
-- Susan Hertzberg, CEO of Prelude Fertility, has more than 25 years of diversified strategic and results-oriented experience in healthcare. In 2014 she received the Ernst & Young’s Entrepreneur Of The Year™ award and sits on the Founders Affiliate Board of the American Heart Association and the Board of Directors for breastcancer.org. Susan received her MBA from Columbia University.
-- Mylene Yao, MD, is CEO and co-founder of Univfy, which combines healthcare artificial intelligence and fintech to dramatically improve fertility patients’ experience, expand affordability of treatment, and maximize a woman’s chances of having a baby from IVF.
-- Anne Morriss, CEO and co-founder, Genepeeks, has an intimate understanding of the urgent need for better genetic information; after using a sperm donor, Anne gave birth to a son with a rare genetic condition that could have been prevented with GenePeeks technology. Anne received her BA in American studies from Brown University and an MBA from Harvard Business School.
-- Rebecca Kaden is a partner at Union Square Ventures where she collaborates with early-stage entrepreneurs building the next generation of great consumer businesses. Previously, she was a partner at Maveron where she invested in and worked with brands such as Allbirds, Periscope, Dia & Co, and Eargo.
This event is organized by Columbia Business School Alumni Club of New York and its Healthcare Committee.
